Current population screening for vascular disease is neither efficient nor effective. Peter Elwood and colleagues believe we should have a public information strategy highlighting the benefits (and risks) of aspirin for older people, but Colin Baigent argues that the evidence of benefit is not yet strong enough
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC558385 | PMC |
| http://dx.doi.org/10.1136/bmj.330.7505.1440 | DOI Listing |
Publication Analysis
Top Keywords
aspirin older
8
older 50?
4
50? current
4
current population
4
population screening
4
screening vascular
4
vascular disease
4
disease efficient
4
efficient effective
4
effective peter
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!